Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

743 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The concept of axial spondyloarthritis: joint statement of the spondyloarthritis research and treatment network and the Assessment of SpondyloArthritis international Society in response to the US Food and Drug Administration's comments and concerns.
Deodhar A, Reveille JD, van den Bosch F, Braun J, Burgos-Vargas R, Caplan L, Clegg DO, Colbert RA, Gensler LS, van der Heijde D, van der Horst-Bruinsma IE, Inman RD, Maksymowych WP, Mease PJ, Raychaudhuri S, Reimold A, Rudwaleit M, Sieper J, Weisman MH, Landewé RB. Deodhar A, et al. Among authors: raychaudhuri s. Arthritis Rheumatol. 2014 Oct;66(10):2649-56. doi: 10.1002/art.38776. Arthritis Rheumatol. 2014. PMID: 25154344 No abstract available.
Current controversies in spondyloarthritis: SPARTAN.
Weisman M, Learch TJ, Baraliakos X, Chandran V, Gladman DD, Raychaudhuri SP, Xu H, Collantes-Estévez E, Vázquez-Mellado J, Mease PJ, Sieper J, Deodhar AA, Colbert RA, Clegg DO; SPARTAN Group. Weisman M, et al. J Rheumatol. 2010 Dec;37(12):2617-23. doi: 10.3899/jrheum.100890. J Rheumatol. 2010. PMID: 21123334
Modulation of Interleukin-23 Signaling With Guselkumab in Biologic-Naive Patients Versus Tumor Necrosis Factor Inhibitor-Inadequate Responders With Active Psoriatic Arthritis.
Siebert S, Coates LC, Schett G, Raychaudhuri SP, Chen W, Gao S, Seridi L, Chakravarty SD, Shawi M, Lavie F, Sharaf M, Zimmermann M, Kollmeier AP, Xu XL, Rahman P, Mease PJ, Deodhar A. Siebert S, et al. Among authors: raychaudhuri sp. Arthritis Rheumatol. 2024 Jan 22. doi: 10.1002/art.42803. Online ahead of print. Arthritis Rheumatol. 2024. PMID: 38253404
Efficacy and safety of tildrakizumab in patients with active psoriatic arthritis: results of a randomised, double-blind, placebo-controlled, multiple-dose, 52-week phase IIb study.
Mease PJ, Chohan S, Fructuoso FJG, Luggen ME, Rahman P, Raychaudhuri SP, Chou RC, Mendelsohn AM, Rozzo SJ, Gottlieb A. Mease PJ, et al. Among authors: raychaudhuri sp. Ann Rheum Dis. 2021 Sep;80(9):1147-1157. doi: 10.1136/annrheumdis-2020-219014. Epub 2021 May 13. Ann Rheum Dis. 2021. PMID: 33985942 Free PMC article. Clinical Trial.
Diagnosis and classification of psoriasis.
Raychaudhuri SK, Maverakis E, Raychaudhuri SP. Raychaudhuri SK, et al. Autoimmun Rev. 2014 Apr-May;13(4-5):490-5. doi: 10.1016/j.autrev.2014.01.008. Epub 2014 Jan 13. Autoimmun Rev. 2014. PMID: 24434359 Review.
743 results